Ignite Creation Date:
2025-12-24 @ 10:58 PM
Ignite Modification Date:
2025-12-31 @ 2:35 AM
Study NCT ID:
NCT04498169
Status:
COMPLETED
Last Update Posted:
2022-09-15
First Post:
2020-07-31
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase 2 Study Evaluating the Safety and Efficacy of Netarsudil Ophthalmic Solution in Patients With Corneal Edema Due to Fuchs Corneal Dystrophy
Sponsor:
Aerie Pharmaceuticals
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
AR-13324-CS210
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None